Compare GeneDx Holdings Corp (WGS) vs W.R. Berkley Corporation Common Stock (WRB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GeneDx Holdings Corp vs W.R. Berkley Corporation Common Stock — how do they compare? GeneDx Holdings Corp trades at $68 (market cap $2.04B), while W.R. Berkley Corporation Common Stock trades at $74.93 (market cap $27.40B). The key difference: W.R. Berkley Corporation Common Stock is far larger — about 13.4× GeneDx Holdings Corp's market cap, and W.R. Berkley Corporation Common Stock pays a 0.54% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold GeneDx Holdings Corp for 20 Days and W.R. Berkley Corporation Common Stock for 0 Days on average.
| WGS | WRB | |
|---|---|---|
Market Cap | $2.04B | $27.40B |
Volume | 962,082 | 2,015,378 |
Sector | Health | Financials |
52-Week High | $167.51 | $78.10 |
52-Week Low | $34.51 | $63.54 |
Typical Hold Time | 20 Days | 0 Days |
Enterprise Value | $2.08B | $27.64B |
Dividend Yield | — | 0.54% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GeneDx (WGS) trades at $64.96, up 1.79% today, showing mixed signals with bearish technical indicators but strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating expectations with record testing volumes, though profitability remains challenged with negative net margins. Recent news highlights product innovations and leadership recognition, while institutional interest grows with Dimensional Fund Advisors increasing its position by 143.4% in Q1 2026.
The stock presents a high-risk opportunity with 91% analyst buy ratings and an $81 consensus target offering 25% upside. However, significant fundamental challenges include negative profitability, high valuation multiples, and cash flow volatility. Investors should weigh strong growth potential in genomic testing against execution risks and competitive pressures in the healthcare technology sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →About W.R. Berkley Corporation Common Stock
W.R. Berkley Corporation is an insurance holding company that underwrites commercial property and casualty insurance and reinsurance through its Insurance and Reinsurance & Monoline Excess segments.
Read more on WRB →
